These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 30489198)
1. Role of CB Magid L; Heymann S; Elgali M; Avram L; Cohen Y; Liraz-Zaltsman S; Mechoulam R; Shohami E J Neurotrauma; 2019 Jun; 36(11):1836-1846. PubMed ID: 30489198 [TBL] [Abstract][Full Text] [Related]
2. Granulocyte Colony-Stimulating Factor Enhances Brain Repair Following Traumatic Brain Injury Without Requiring Activation of Cannabinoid Receptors. Song S; Kong X; Borlongan C; Sava V; Sanchez-Ramos J Cannabis Cannabinoid Res; 2021; 6(1):48-57. PubMed ID: 33614952 [No Abstract] [Full Text] [Related]
3. Selective activation of cannabinoid receptor-2 reduces neuroinflammation after traumatic brain injury via alternative macrophage polarization. Braun M; Khan ZT; Khan MB; Kumar M; Ward A; Achyut BR; Arbab AS; Hess DC; Hoda MN; Baban B; Dhandapani KM; Vaibhav K Brain Behav Immun; 2018 Feb; 68():224-237. PubMed ID: 29079445 [TBL] [Abstract][Full Text] [Related]
4. CB2 cannabinoid receptor is involved in the anti-inflammatory effects of leptin in a model of traumatic brain injury. Lopez-Rodriguez AB; Mela V; Acaz-Fonseca E; Garcia-Segura LM; Viveros MP Exp Neurol; 2016 May; 279():274-282. PubMed ID: 27006282 [TBL] [Abstract][Full Text] [Related]
5. The synthetic cannabinoid WIN55212-2 ameliorates traumatic spinal cord injury via inhibition of GAPDH/Siah1 in a CB2-receptor dependent manner. Su BX; Chen X; Huo J; Guo SY; Ma R; Liu YW Brain Res; 2017 Sep; 1671():85-92. PubMed ID: 28716633 [TBL] [Abstract][Full Text] [Related]
6. Biological characterization of PM226, a chromenoisoxazole, as a selective CB2 receptor agonist with neuroprotective profile. Gómez-Cañas M; Morales P; García-Toscano L; Navarrete C; Muñoz E; Jagerovic N; Fernández-Ruiz J; García-Arencibia M; Pazos MR Pharmacol Res; 2016 Aug; 110():205-215. PubMed ID: 27013280 [TBL] [Abstract][Full Text] [Related]
7. Cannabinoid CB Spiller KJ; Bi GH; He Y; Galaj E; Gardner EL; Xi ZX Br J Pharmacol; 2019 May; 176(9):1268-1281. PubMed ID: 30767215 [TBL] [Abstract][Full Text] [Related]
8. A new cannabinoid CB2 receptor agonist HU-910 attenuates oxidative stress, inflammation and cell death associated with hepatic ischaemia/reperfusion injury. Horváth B; Magid L; Mukhopadhyay P; Bátkai S; Rajesh M; Park O; Tanchian G; Gao RY; Goodfellow CE; Glass M; Mechoulam R; Pacher P Br J Pharmacol; 2012 Apr; 165(8):2462-78. PubMed ID: 21449982 [TBL] [Abstract][Full Text] [Related]
9. Cannabinoid CB1 and CB2 receptor ligand specificity and the development of CB2-selective agonists. Ashton JC; Wright JL; McPartland JM; Tyndall JD Curr Med Chem; 2008; 15(14):1428-43. PubMed ID: 18537620 [TBL] [Abstract][Full Text] [Related]
10. Selective activation of cannabinoid receptor-2 reduces white matter injury via PERK signaling in a rat model of traumatic brain injury. Li L; Luo Q; Shang B; Yang X; Zhang Y; Pan Q; Wu N; Tang W; Du D; Sun X; Jiang L Exp Neurol; 2022 Jan; 347():113899. PubMed ID: 34678230 [TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo pharmacology of synthetic olivetol- or resorcinol-derived cannabinoid receptor ligands. Cascio MG; Bisogno T; Palazzo E; Thomas A; van der Stelt M; Brizzi A; de Novellis V; Marabese I; Ross R; van de Doelen T; Brizzi V; Pertwee R; Maione S; Di Marzo V Br J Pharmacol; 2006 Oct; 149(4):431-40. PubMed ID: 16953186 [TBL] [Abstract][Full Text] [Related]
12. The fatty acid amide hydrolase inhibitor PF-3845 promotes neuronal survival, attenuates inflammation and improves functional recovery in mice with traumatic brain injury. Tchantchou F; Tucker LB; Fu AH; Bluett RJ; McCabe JT; Patel S; Zhang Y Neuropharmacology; 2014 Oct; 85():427-39. PubMed ID: 24937045 [TBL] [Abstract][Full Text] [Related]
17. Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB Navarro G; Varani K; Lillo A; Vincenzi F; Rivas-Santisteban R; Raïch I; Reyes-Resina I; Ferreiro-Vera C; Borea PA; Sánchez de Medina V; Nadal X; Franco R Pharmacol Res; 2020 Sep; 159():104940. PubMed ID: 32470563 [TBL] [Abstract][Full Text] [Related]
18. CB1 and CB2 cannabinoid receptor antagonists prevent minocycline-induced neuroprotection following traumatic brain injury in mice. Lopez-Rodriguez AB; Siopi E; Finn DP; Marchand-Leroux C; Garcia-Segura LM; Jafarian-Tehrani M; Viveros MP Cereb Cortex; 2015 Jan; 25(1):35-45. PubMed ID: 23960212 [TBL] [Abstract][Full Text] [Related]
19. Targeting CB2 receptors and the endocannabinoid system for the treatment of pain. Anand P; Whiteside G; Fowler CJ; Hohmann AG Brain Res Rev; 2009 Apr; 60(1):255-66. PubMed ID: 19150370 [TBL] [Abstract][Full Text] [Related]
20. Identification and biochemical analyses of selective CB Scott CE; Tang Y; Alt A; Burford NT; Gerritz SW; Ogawa LM; Zhang L; Kendall DA Eur J Pharmacol; 2019 Jul; 854():1-8. PubMed ID: 30951717 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]